Skip to search formSkip to main contentSkip to account menu

Targeted Accrual

Known as: Protocol Targeted Accrual, Study Targeted Accrual, Study Target Accrual 
The final sample size that must be attained according to the study protocol.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1–Infected Individuals: SWIFT-C
Background Historically, acute hepatitis C virus (HCV) infection was treated with shorter durations of interferon-containing… 
Highly Cited
2015
Highly Cited
2015
High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement…
PURPOSE Treatment of secondary CNS dissemination in patients with aggressive lymphomas remains an important, unmet clinical need… 
Highly Cited
2013
Highly Cited
2013
Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized…
PURPOSE Apart from localized gastric disease, there is no consensus on standard initial treatment of mucosa-associated lymphoid… 
2012
2012
Five-year local control in a phase II study of hypofractionated intensity modulated radiation therapy with an incorporated boost for early stage breast cancer.
2011
2011
Final results of a phase II randomized trial of neoadjuvant anthracycline-taxane chemotherapy plus lapatinib, trastuzumab, or both in HER2-positive breast cancer (CHER-LOB trial).
507 Background: This is a randomized phase II trial of preoperative taxane-anthracycline in combination with trastuzumab… 
2009
2009
Outcomes following vaginal prolapse repair and mid urethral sling (OPUS) trial—design and methods
Background The primary aims of this trial are to determine whether the use of a concomitant prophylactic anti-incontinence… 
2009
2009
Pegylated liposomal doxorubicin and trastuzumab as 1st and 2nd line therapy in her2/neu positive metastatic breast cancer: a multicenter phase II trial
The combination therapy of doxorubicin and trastuzumab has been proven to be highly effective for metastatic breast cancer (MBC… 
2006
2006
The triplet combination of irinotecan, oxaliplatin and 5FU/LV (FOLFOXIRI) vs the doublet of irinotecan and 5FU/LV (FOLFIRI) as first-line treatment of metastatic colorectal cancer (MCRC): Results of…
3513 Background: We demonstrated interesting activity and manageable toxicities for the FOLFOXIRI regimen in phase I-II studies… 
2001
2001
Randomized controlled trial of ovarian function suppression plus tamoxifen versus the same endocrine therapy plus chemotherapy: is chemotherapy necessary for premenopausal women with node-positive…
Highly Cited
1996
Highly Cited
1996
A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer
Randomized clinical trials have clearly demonstrated that the use of radiation therapy (RT) following breast‐conserving surgery… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)